Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) has finalized the acquisition of Dura Driver Control Systems, making it a wholly owned subsidiary.
The transaction involved the purchase of all issued and outstanding shares of Dura Driver Control Systems for approximately $30 million in cash.
RBW Capital Partners LLC served as the exclusive financial advisor to Aspire Biopharma Holdings for this acquisition.
"Closing the DCS acquisition is a cash-flow-positive milestone that structurally enhances Aspire's valuation," said Kraig Higginson, CEO and Chairperson of the Aspire's Board. "Absorbing DCS's FY2025 financial footprint-exceeding $200 million in revenue and $22.3 million in Adjusted EBITDA1 in 2025-immediately elevates us to enterprise scale. "